htd1801
Showing 1 - 4 of 4
Nonalcoholic Steatohepatitis (NASH) Trial in Miami Lakes, Tulsa, Waco (HTD1801, Placebo)
Recruiting
- Nonalcoholic Steatohepatitis (NASH)
- HTD1801
- Placebo
-
Miami Lakes, Florida
- +2 more
Jan 13, 2023
Primary Sclerosing Cholangitis (PSC) Trial in Canada, United States (HTD1801, Placebo)
Completed
- Primary Sclerosing Cholangitis (PSC)
- HTD1801
- Placebo
-
Chandler, Arizona
- +25 more
Mar 13, 2022
Fatty Liver, Nonalcoholic, NAFLD, Nonalcoholic Fatty Liver Disease Trial in United States (HTD1801, Placebo)
Completed
- Fatty Liver, Nonalcoholic
- +5 more
- HTD1801
- Placebo
-
Chandler, Arizona
- +16 more
Nov 30, 2021
Primary Sclerosing Cholangitis Trial in Melbourne (HTD1801)
Completed
- Primary Sclerosing Cholangitis
- HTD1801
-
Melbourne, Victoria, AustraliaNucleus Network Limited
Jul 23, 2020